Primary Job Title Board Of Directors Primary Organization Loxo Oncology
Gender Male
Steve joined Aisling Capital in mid-2000 and currently serves as a Managing Partner. Previously, he was a Principal in the Life Sciences Investment Banking Group of Hambrecht & Quist (H & Q). During his five years at H & Q, Steve was involved in over 60 financing and M&A transactions, helping clients raise in excess of $3.3 billion
in capital. Prior to H & Q, he traded mortgage-backed securities at Donaldson, Lufkin & Jenrette. His previous healthcare sector experience includes over two years as a pharmaceutical sales representative for Marion Laboratories and two years as a consultant for The Wilkerson Group. Steve currently serves as a director of Pernix Therapeutics, Inc. (AMEX: PTX) and a number of private companies.
Steve Elms - Mr. Elms is currently a Managing Partner at Aisling Capital, a leading private equity fund investing in life science companies, and serves on the board of a number of public and private life sciences companies.
Previously, Mr. Elms was a senior member of the Life Sciences Investment Banking Group of Hambrecht & Quist and was involved in over 60 financing and M&A transactions, which helped clients raise in excess of $3.3 billion in capital. His previous healthcare sector experience includes over two years as a pharmaceutical sales representative for Marion Laboratories.
Steve earned an M.B.A. from the Kellogg Graduate School of Management at Northwestern University and a B.A. in Human Biology from Stanford University.
